Orange Book product · Brand (NDA)
MINIPRESS
PRAZOSIN HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
PRAZOSIN HYDROCHLORIDE
Strength
EQ 2MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 017442
Product number
003
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1992MINIPRESS XLBrand (NDA)
NDA 019775 · PFIZER
- 2024PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216727 · MSN
- 2024PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214083 · LANNETT CO INC
- 2023PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213052 · AUROBINDO PHARMA LTD
- 2023PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217268 · ALEMBIC
- 2022PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215697 · MANKIND PHARMA
- 2022PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 213406 · APPCO
- 2021PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 214608 · GRANULES
- 2018PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 210971 · NOVITIUM PHARMA
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072782 · AM THERAP
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072783 · AM THERAP
- 1989PRAZOSIN HYDROCHLORIDEGeneric (ANDA)
ANDA 072784 · AM THERAP
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
